Treating Hyperexcitability in AD With Levetiracetam

Clinical trial NCT03875638 · COMPLETED

Trial details

NCT number: NCT03875638
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Dementia Alzheimer Disease Dementia of Alzheimer Type Mild Cognitive Impairment

Start date: 2019-08-22
Primary completion: 2026-02-16
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.